Publication | Closed Access

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

MedicinePathologyPleural DiseaseCancer TreatmentOncologyRadiation OncologyCancer ResearchPleural Mesothelioma